Adjuvant radiotherapy improves progression-free survival in intracranial atypical meningioma

BACKGROUND: Meningiomas are the most common primary tumors of the central nervous system. In patients with WHO grade I meningiomas no adjuvant therapy is recommended after resection. In case of anaplastic meningiomas (WHO grade III), adjuvant fractionated radiotherapy is generally recommended, regar...

Descripción completa

Detalles Bibliográficos
Autores principales: Hemmati, Saman Moritz, Ghadjar, Pirus, Grün, Arne, Badakhshi, Harun, Zschaeck, Sebastian, Senger, Carolin, Acker, Güliz, Misch, Martin, Budach, Volker, Kaul, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6719347/
https://www.ncbi.nlm.nih.gov/pubmed/31477146
http://dx.doi.org/10.1186/s13014-019-1368-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6719347/
https://www.ncbi.nlm.nih.gov/pubmed/31477146
http://dx.doi.org/10.1186/s13014-019-1368-z

Ejemplares similares